A Review of Pleiotropic Potential of Erythropoietin as an Adjunctive Therapy for COVID-19
Coronavirus disease 2019 (COVID-19) is a severe acute respiratory disease with a high prevalence. According to the research and statistical data, in January 2021, there have been 92,262,621 confirmed cases of COVID-19 and more than two million deaths. Infection with the severe acute respiratory synd...
Main Authors: | Fatemeh EmamiPari, Soroush Kamali, Ghazaleh Nikzad, Narges Roosta Navi, Sanaz Soltani, Mohamad Reza Kalani |
---|---|
Format: | Article |
Language: | English |
Published: |
Golestan University Of Medical Sciences
2022-02-01
|
Series: | Journal of Clinical and Basic Research |
Subjects: | |
Online Access: | http://jcbr.goums.ac.ir/article-1-324-en.html |
Similar Items
-
Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01) -
Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
by: Shujaaedin, Hareth Yahya Ahmed
Published: (2019) -
Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
by: Bongki Cho, et al.
Published: (2022-02-01) -
Expression of erythropoietin and its receptor increases in colonic neoplastic progression: The role of hypoxia in tumorigenesis
by: Zoltan Gombos, et al.
Published: (2011-01-01) -
Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
by: Shuo Miao, et al.
Published: (2017-12-01)